Skip to main content
. Author manuscript; available in PMC: 2022 Apr 11.
Published in final edited form as: J Clin Epidemiol. 2021 Mar 28;137:45–57. doi: 10.1016/j.jclinepi.2021.03.021

Table 4.

Trial participant, intervention, and other descriptors in registry (Data source: ClinicalTrials.gov, N = 1988).

Item N (%)
Participant Sex
 Female only 225 (11.3%)
 Male only 29 (1.5%)
 Both 1730 (87%)
 Missing 4 (0.2%)
Participant Age *
 Children (< 18) only 268 (13.5%)
 Senior (65+) only 72 (3.6%)
 Mixed ages 1617 (81.3%)
 Missing 31 (1.6%)
Phase (categories as in ClinicalTrials.gov)
 Early Phase 1 12 (0.6%)
 Phase 1 9 (0.5%)
 Phase 1/Phase 2 15 (0.8%)
 Phase 2 63 (3.2%)
 Phase 2/Phase 3 38 (1.9%)
 Phase 3 208 (10.5%)
 Phase 4 244 (12.3%)
 Phase N/A 1368 (68.8%)
 Missing 31 (1.6%)
Type of intervention (categories as in ClinicalTrials.gov)Ψ
 Behavioral 903 (45.4%)
 Biological 41 (2.1%)
 Device 155 (7.8%)
 Dietary 53 (2.7%)
 Drug 324 (16.3%)
 Procedure 128 (6.4%)
 Radiation 10 (0.5%)
 Other 635 (31.9%)
 Missing 14 (0.7%)
Primary purpose (categories as in ClinicalTrials.gov)
 Treatment 746 (37.5%)
 Prevention 500 (25.2%)
 Health Services Research 342 (17.2%)
 Supportive Care 158 (7.9%)
 Screening 53 (2.7%)
 Basic Science 8 (0.4%)
 Diagnostic 66 (3.3%)
 Education/Counseling 1 (0.1%)
 Other 38 (1.9%)
 Missing 76 (3.8%)
Number of primary outcomes
 Min, Max 1, 20
 Median (Q1–Q3) 1 (1–1)
 Mean (SD) 1.46 (1.21)
 1 1516 (76.2%)
 2 279 (14%)
 3 or more 186 (9.4%)
 Missing 7 (0.4%)
Masking
 None 1005 (50.6%)
 Single 588 (29.5%)
 Double 172 (8.6%)
 Triple 72 (3.6%)
 Quadruple 106 (5.3%)
 Missing 45 (2.3%)
Number of facilities
 Min, Max 1, 916
 Median (Q1–Q3) 1 (1–2)
 Mean (SD) 8.6 (45.4)
 1 1203 (61%)
 > 1 619 (31.1%)
 Missing 166 (8.4%)
*

Using the minimum and maximum ages a potential participant must be to be eligible for the study, we established whether a trial solely involved children or infants (applying an upper threshold of 18 years using the maximum age category, and applying no minimum threshold), an older population (applying a lower threshold of 65 years using the minimum listed age for participants and no maximum age limit), or included a mix of ages.

Ψ

Does not sum to 100% as trials may have multiple interventions.